SCHEMBL6567047

SCHEMBL6567047

COC(=O)c1cc(NC(=O)Nc2cccc(C#N)c2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
ALDH1A1 P00352 3/20 0.52
LMNA P02545 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
HTT P42858 2/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
PPIA P62937 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
GAA P10253 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP7 P55210 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KCNJ6 P48051 1/20 0.44
KCNJ5 P48544 1/20 0.44
KCNJ3 P48549 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566851 0.92 MEN1 (0.50) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6564786 0.88 KMT2A (0.61) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6567738 0.87 MEN1 (0.47) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6567728 0.87 MEN1 (0.48) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6566290 0.85 MGLL (0.53) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6566601 0.85 LMNA (0.53) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6567055 0.84 MEN1 (0.64) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6566773 0.84 LMNA (0.56) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6568001 0.84 ALDH1A1 (0.52) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL6564574 0.84 TSHR (0.55) MAPTMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MAPT 4743/4885MEN1 4143/4885KMT2A 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.